Innovation in Medicon Valley

An innovation report from Medicon Valley Alliance. The report includes:

• A presentation of Medicon Valley’s innovation environment
• Five recommendations for new national and regional measures in the area of innovation

In Medicon Valley, EUR 300 million is spent annually on biotechnological and pharmaceutical research and development at the universities and hospitals. However, a number of recent Danish and Swedish reports have pointed out that much of the knowledge created in public sector research institutes is not being commercially utilised, despite its potential. The innovation systems in the two countries are simply not doing as well as they should.

At the end of 2003, Medicon Valley Alliance appointed a strategic innovation group to provide an overall view of the strengths and weaknesses of the current innovation systems in Denmark and Sweden. The resulting analysis confirms Medicon Valley's weak innovation efforts compared to three other bioregions: Oxford and Stockholm in Europe, and Stanford University in Silicon Valley, USA.

The conclusion is that there is a need for a number of new measures to strengthen innovation efforts in the region. The report presents five national and regional recommendations aimed at creating more hi-tech workplaces in Denmark and Sweden.

Download the report by clicking here (pdf)

If you need more information regarding the innovation report, please contact Stina Gestrelius at +46 46 286 3323.